Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients

This study has been terminated.
(Study stopped due to low accrual)
Sponsor:
Information provided by:
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00351715
First received: July 11, 2006
Last updated: January 24, 2013
Last verified: October 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2008
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)